Buys
Open market- Shares
- Avg price
- Total value
Ezra M. Friedberg - Director at Pelthos Therapeutics Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- PTHS on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Ezra M. Friedberg in Pelthos Therapeutics Inc.
Sells
Open market- Shares
- -11,399
- Avg price
- $27.57
- Total value
- -$314,232
Net
Past year- Shares
- -11,399
- Share %
- -100%
- Total value
- -$314,232
Reported holdings for Ezra M. Friedberg in Pelthos Therapeutics Inc.
Form 4 holding
Director
Pelthos Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 81,042
- Estimated value
- $2,214,505
- Report date
- 02 Jul 2026
- Price
- $27.33
- Ownership
- Direct
Form 4 holding
Director
Pelthos Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 82,072
- Estimated value
- $1,724,332
- Report date
- 02 Jul 2026
- Price
- $21.01
- Ownership
- By Balmoral Financial Group LLC
Form 4 holding
Director
Pelthos Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 40,000
- Estimated value
- $840,400
- Report date
- 02 Jul 2026
- Price
- $21.01
- Ownership
- By Key Recovery Group LLC
Form 4 holding
Director
Channel Therapeutics Corp
- Security class
- Restricted Stock Units
- Shares / value
- 28,012
- Estimated value
- $615,709
- Report date
- 02 Jul 2025
- Price
- $0.9700
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Channel Therapeutics Corp
- Security class
- Stock Option
- Shares / value
- 58,230
- Estimated value
- Report date
- 02 Jul 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Channel Therapeutics Corp
- Security class
- Series A Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 01 Jul 2025
- Price
- Ownership
- By Balmoral Financial Group LLC
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Channel Therapeutics Corp
- Security class
- Series A Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 01 Jul 2025
- Price
- Ownership
- By Key Recovery Group LLC
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Ezra M. Friedberg in Pelthos Therapeutics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.